Skip to main content
Back to Gaingels

Gaingels's Biotechnology Portfolio

Browse 49 Biotechnology companies funded by Gaingels. See funding amounts, founder contacts, and investment details.

Biotechnology Companies
49
Total Funding in Biotechnology
$1.2B

Biotechnology Portfolio Companies (49)

Export
BiotechnologyHealth CareTherapeutics

Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.

Philadelphia, United States
September 2022
$6.8M
Grant

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedical

Centenara Labs is an integrated biotechnology platform company that invests in people and ideas to develop therapies.

Schlieren, Switzerland
September 2023
Debt Financing

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedical

Seismic Therapeutic is a biotechnology company developing machine-learning technology for immunology drug development.

Watertown, United States
September 2024
$25.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyManufacturingProduct ResearchSustainability

MycoWorks is a biotechnology company that offers non-plastic and non-animal materials to the market.

Emeryville, United States
July 2024
Series D

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyMedicalTherapeutics

BigHat Biosciences is a protein therapeutics company that develops an antibody design platform guided by artificial intelligence.

San Mateo, United States
July 2022
$75.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyLife Science

NKGen Biotech is restoring immune function through the development of unique natural killer (NK) cell therapies for the treatment of cancer.

Santa Ana, United States
July 2025
$2.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedical

Notable Labs provides personalized drug combination testing service for cancer patients.

Foster City, United States
July 2022
$189K
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyOncology

Alnair Therapeutics is a preclinical stage precision oncology platform focusing on developing innovative approaches to treat difficult.

Chicago, United States
June 2023
$1.0M
Pre-Seed

Founder Contacts

30,000+ verified contacts

BiotechnologyClinical TrialsHealth CareMedicalMedical DeviceRobotics

Vixiar Medical develops non-invasive, cost-effective devices and systems for monitoring cardiopulmonary diseases.

Baltimore, United States
June 2023
Undisclosed

Founder Contacts

30,000+ verified contacts

BiotechnologyChemical EngineeringFood and BeverageFood ProcessingManufacturingWaste Management

Hyfé turns food waste into chemicals that maximize profits for food processors while allowing the world to make products without petroleum.

Chicago, United States
June 2023
$9.0M
Seed

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Beren Therapeutics is a biotechnology company that develops innovative therapies to make them accessible to every patient.

Thousand Oaks, United States
June 2026
$165.0M
Debt Financing

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareLife ScienceOncologyTherapeutics

Cartography is an oncology company that develops cancer immunotherapies that target novel and highly specific tumor antigens.

South San Francisco, United States
May 2026
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceRobotics

Trilobio develops an automated laboratory platform that combines robotics, software, and tools to execute biological experiments.

San Francisco, United States
May 2025
$8.0M
Seed

Founder Contacts

30,000+ verified contacts

BiotechnologyLife Science

Mapping interactions foundational to therapeutic discovery and human health.

Monmouth Junction, United States
May 2026
$48.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyFashionManufacturing

VitroLabs develops a platform that manufactures real leather using stem cell-based technologies.

San Jose, United States
May 2022
$126K
Series A

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyGeneticsTherapeutics

Latus Bio develops gene therapy candidates, particularly for treating central nervous system (CNS) disorders using screened AAV capsids.

Philadelphia, United States
May 2026
$43.0M
Series A

Founder Contacts

30,000+ verified contacts

Biotechnology

Karma Biotechnologies is solving autoimmunity, allergies, and food sensitivities with our Xavine™ precision immunotherapy platform.

Torrance, United States
May 2023
$31K
Seed

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareOncologyVeterinary

Torigen Pharmaceuticals focuses on providing cancer care solutions for animals.

Farmington, United States
May 2022
$13.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Senti Bio is a clinical-stage biotechnology company developing a new generation of cell and gene therapies for cancer.

South San Francisco, United States
May 2026
$10.0M
Post-IPO Debt

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CarePrecision MedicineTherapeutics

Bionaut Labs revolutionizes the treatment of central nervous system disorders with its precision medicine treatment modality.

Los Angeles, United States
May 2024
$712K
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyTherapeutics

Swing Therapeutics provides digital therapeutics for people with chronic conditions.

San Francisco, United States
May 2026
Grant

Founder Contacts

30,000+ verified contacts

BiotechnologyFertilityHealth CareTherapeutics

Granata Bio is a biotechnology company developing therapeutic solutions to address infertility and improve women's reproductive health.

Duxbury, United States
May 2025
Corporate Round

Founder Contacts

30,000+ verified contacts

BabyBiotechnologyHealth CareNutritionWellness

ByHeart is a baby nutrition company with FDA-registered infant formula.

New York, United States
May 2024
$95.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyLife Science

Catena Biosciences is a biotechnology company that offers protein conjugation, building biologic structures, and medical research.

Berkeley, United States
May 2024
$2.4M
Seed

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedical

Antiva Biosciences is a biopharmaceutical company developing therapeutics for the treatment of diseases caused by HPV infection.

Del Mar, United States
April 2023
$53.0M
Series E

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyEmergency MedicineHealth CareMachine Learning

Future Fertility is a provider of artificial intelligence tools for reproductive medicine.

Toronto, Canada
April 2026
$4.1M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyLife Science

Octant Bio is a developer of synthetic technology used to improve health and treat disease.

Los Angeles, United States
April 2022
$80.0M
Series B

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyRobotics

twig bio operates as a bioengineering startup.

London, United Kingdom
April 2026
Grant

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyLife ScienceTherapeutics

Alloy Therapeutics is a biotechnology company that provides drug discovery services to support the development of therapeutic biologics.

Waltham, United States
April 2026
$40.0M
Series E

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsLife Science

Minicircle develops a human genetic enhancement platform to facilitate life extension capabilities.

Los Angeles, United States
April 2024
$459K
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedical Device

Ossium Health builds a bone marrow bank to treat blood cancers.

San Francisco, United States
April 2026
$15K
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

Advanced MaterialsAgricultureBiotechnologyFood and BeverageNutritionOrganic FoodProfessional Services

MycoTechnology utilizes fungi-based food-processing platforms to transform the flavor and value of agricultural products.

Aurora, United States
March 2022
$85.0M
Series E

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyLife ScienceTherapeutics

HexemBio develops a synthetic human Yolk Sac platform to rejuvenate blood stem cells to extend healthy lifespan.

Los Angeles, United States
March 2026
$10.4M
Seed

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalMental HealthPharmaceutical

Gilgamesh Pharmaceuticals is a clinical-stage biotechnology company that develops psychedelic and related drugs to treat mental illnesses.

New York, United States
March 2026
$60.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareInformation Technology

ImmuneBridge is developing allogeneic immunotherapies for cancer.

San Francisco, United States
March 2026
$7.7M
Seed

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiopharmaBiotechnologyNeurosciencePrecision Medicine

Alto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.

Los Altos, United States
March 2026
$120.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

Biotechnology

XYLO is a biotechnology firm that offers services for neurological and psychiatric conditions.

Boulder, United States
February 2025
Seed

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsHealth Care

Humane Genomics is a virus development platform that develops artificial viruses to cure diseases.

New York, United States
February 2025
$4.0M
Seed

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife Science

Glyphic Biotechnologies is a biotechnology company that develops a protein sequencing platform.

New York, United States
September 2025
$38.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife ScienceNeuroscience

Delix Therapeutics focuses on harnessing the power of psychoplastogens novel neuroplasticity-promoting therapeutic.

Boston, United States
September 2025
$25.0M
Series B

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyGeneticsLife Science

Gameto is a biotechnology company developing therapeutics of the female reproductive system using cell engineering.

New York, United States
August 2025
$44.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedical Device

Cooler Heads develops a portable scalp cooling system designed for chemotherapy patients.

San Diego, United States
July 2025
$11.0M
Series A

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyLife SciencePharmaceutical

Synfini is a drug discovery platform combining AI, chemistry automation, and cloud tools to design improved molecules.

Menlo Park, United States
July 2025
$8.9M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth Care

Biostate AI develops generative AI that benefit all human health.

Palo Alto, United States
May 2025
$12.0M
Series A

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth CareLife SciencePharmaceutical

Ignota Labs recognizes that safety errors during the drug discovery process.

London, United Kingdom
February 2025
$6.9M
Seed

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedical

Qnovia is a platform medtech and pharmaceutical company whose mission is to help save lives.

Richmond, United States
December 2024
$16.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedical

Sonavex is a developer of an imaging technology designed to visualize and quantify critical data to detect anastomotic blood clots.

Baltimore, United States
October 2024
$15.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Arda is taking aim at chronic diseases and aging by eliminating the pathogenic cells that drive these conditions.

San Francisco, United States
October 2024
$43.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareOncologyTherapeutics

VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection.

Baltimore, United States
September 2024
$4.5M
Seed

Founder Contacts

30,000+ verified contacts

Explore Gaingels's Full Portfolio

View all companies funded by Gaingels across every industry and funding stage.

View Full Gaingels Portfolio